Purchase Order 75F40126P00224

<p>The FDA's Office of Acquisition and Grants Services issued a purchase order to Sotax Corp on July 10, 2023, for an automated disintegration tester, with a ceiling value of $18,901.92. The order carries no set-aside designation. Performance occurs in Westborough, Massachusetts. The firm-fixed-price purchase order is for pharmaceutical testing equipment supporting FDA regulatory compliance and drug evaluation activities. Ultimate completion is scheduled for July 29, 2024.</p>

<p>The Food and Drug Administration awarded a purchase order to Distek Inc. for $19,520.40 on July 22, 2026, for an automated media preparation instrument for dissolution testing under Executive Order 14398. Place of performance is Irvine, California. The order carries no set-aside. Ultimate completion is October 25, 2027. Pricing is firm fixed price.</p>

The Food and Drug Administration (FDA) awarded a $96,929.40 firm-fixed-price purchase order to Agilent Technologies Inc. to provide three dissolution apparatus systems with sampling units, temperature probes, vessels, and other accessories. The FDA's Division of Product Quality Research has a requirement for this specialized laboratory equipment. The contract has an ultimate completion date of May 14, 2022 and was awarded on April 13, 2021. This purchase order is not associated with a...

The U.S. Food and Drug Administration (FDA) awarded a $76,915.84 firm-fixed-price purchase order to Sotax Corp, a manufacturer of pharmaceutical testing equipment, to provide a dissolution instrument with UV/Vis spectrometer and auto sampler. This equipment will be used by the FDA's Detroit Laboratory to conduct dissolution analysis on pharmaceutical medication samples, including from Department of Defense (DOD) and Veterans Administration (VA) stockpiles, to ensure acceptable dosing limits. The...

<p>The Food and Drug Administration awarded a purchase order to Waters Technologies Corporation on August 6, 2026, for a field-flow fractionation multi-angle light scattering system with size exclusion chromatography and multi-angle light scattering/refractive index/ultraviolet capability, with a ceiling value of $424,189.44. Work is performed in Cincinnati, Ohio, with an ultimate completion date of August 5, 2027. The order is firm fixed price with no set-aside applied.</p>

The Food and Drug Administration issued a delivery order to Technical Communities, Inc. on September 11, 2023, with a ceiling value of $49,505.51, to purchase one Agilent Life Sciences G4557A 7697A headspace sampler with accessories and related control software and interface components. The order is firm-fixed-price and was issued under the GSA Multiple Award Schedule as a total small business set-aside. Place of performance is Irvane, CA. The ultimate completion date is September 12, 2024. This...

<p>The Food and Drug Administration issued a $53,678.71 delivery order to Waters Technologies Corporation on July 8, 2026, for high-performance liquid chromatography (HPLC)-photodiode array detector (PDA) system service under the GSA Multiple Award Schedule (MAS).</p> <p>Place of performance is Milford, MA. The order extends through July 9, 2031, and is priced on a firm fixed-price basis. Waters serves as prime contractor without named subcontractors on this engagement.</p>

<p>The Food and Drug Administration issued a purchase order to Cenmed Enterprises Inc. for $202,816.33 on May 7, 2020, under a Total Small Business set-aside, for an ACQUITY UPLC H Class Plus system with service contract coverage. The order closes on February 16, 2026. Place of performance is Silver Spring, Maryland. The purchase order carries firm fixed pricing.</p>

The Food and Drug Administration awarded a purchase order to Distek Inc. for a dissolution system and autosampler instrument valued at $70,905.15, with an award date of August 3, 2026 and ultimate completion by October 3, 2027. The system will be delivered and installed at the Irvine Medical Products Laboratory in Irvine, California. The equipment supports dissolution testing of extended-release dosage forms and includes syringe pumps with interchangeable paddle or basket configurations,...

The Food and Drug Administration issued a delivery order to Agilent Technologies Inc. on August 27, 2025, for a liquid chromatography system with absorbance (UV/DAD) and fluorescence detectors (bioinert chromatography system), with a ceiling value of $185,730.55. The order was issued under the General Services Administration Multiple Award Schedule (MAS). Place of performance is Marshallton, Delaware. The order carries a firm fixed price and an ultimate completion date of December 8, 2030. No...